Main Menu

Translational Immunotherapy Group

Professor Alan Melcher's group is looking at ways to activate the immune system to attack cancer using therapeutic viruses. These agents are already approved for clinical use and offer major potential benefits to further improve the promising field of immunotherapy.

Group leader

Professor Alan Melcher

Professor Alan Melcher

Professor Melcher is a clinician scientist studying how to activate the immune system to recognise and attack cancer. In particular, he works on oncolytic, anti-cancer viruses, which work mainly as a type of immunotherapy, and is a specialist in melanoma and head and neck cancer.

ORCID 0000-0002-2042-3380

Group members

Dr Irene Chong
Dr Irene Chong 
Group Leader

Dr Irene Chong is a Clinician Scientist at The Institute of Cancer Research, London, and a Consultant Clinical Oncologist at The Royal Marsden NHS Foundation Trust.

Dr Lauren Aronson
Senior Scientific Officer T +44 20 3437 7559
Dr Ben Challoner
Honorary Appointment
Dr Charleen Chan
Clinical Research Fellow
Dr Shane Foo
Dr Shane Foo
Senior Scientific Officer T +44 20 7153 5538
Lorna Grove
Higher Scientific Officer
Dr Vicki Jennings
Post-doctoral Researcher
Dr Nitya Mohan
Postdoctoral Training Fellow T +44 20 3437 7017
Dr Carmen Murano
Higher Scientific Officer T +44 20 3437 7032
Dr Malin Pedersen
Senior Staff Scientist T +44 20 3437 7575
Shivanki Sahay
Scientific Officer T +44 20 3437 6245
Sreelakshmi Sasidharan
Scientific Officer T +44 20 3437 6919
Lauren Warner
Scientific Officer T +44 20 3437 6300